# NIPRIDE RTU IN SODIUM CHLORIDE 0.9%
> **NDA209387** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2017-03-08
## Drug
- **FDA Application Number:** NDA209387
- **Application type:** New Drug Application
- **Brand name:** NIPRIDE RTU IN SODIUM CHLORIDE 0.9%
- **Generic name:** SODIUM NITROPRUSSIDE
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EXELA PHARMA
- **Manufacturer:** EXELA PHARMA SCIENCES, LLC
- **First approval:** 2017-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209387)
---
*AI Analytics · CC0 1.0*